Article info
Correspondence
Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis
- Correspondence to Prof Mendel E Singer, Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA; mendel{at}case.edu
Citation
Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis
Publication history
- Received July 3, 2020
- Revised July 15, 2020
- Accepted July 18, 2020
- First published August 5, 2020.
Online issue publication
October 18, 2023
Article Versions
- You are viewing the most recent version of this article.
- Previous version (18 October 2023).
- latest version (18 October 2023).
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage